| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/11/2002 | US6403363 Method of preservation of vaccines with polybiguanide |
| 06/11/2002 | US6403125 Pronounced action on lipolysis so useful in slimming preparations, but also owing to their tightening effect, their smoothing properties and the improvement of the radiance of the skin. |
| 06/11/2002 | US6403123 Topical application of anthralin that results in minimal or no staining of skin or clothing; applying a wax formulation over the involved area |
| 06/11/2002 | US6403122 Bioavailability based on a lipolytic indifferent vehicle, an absorption promoter and active n-methylated cyclic undecapeptides or macrolide lactones; self assembly drug delivery system (sadds); cyclosporins |
| 06/11/2002 | US6403121 Of a biquamide, metformin, and coating of pioglitazone hydrochloride; modulating release polymer comprising a polysaccharide, alginate; antidiabetic |
| 06/11/2002 | US6403120 Extended release formulation of venlafaxine hydrochloride |
| 06/11/2002 | US6403119 Discoloration-resistant vitamin composition |
| 06/11/2002 | US6403117 Archaesomes, archaeosomes containing coenzyme Q10 and other types of liposomes containing coenzyme Q10 adjuvants and as delivery vehicles |
| 06/11/2002 | US6403116 Dimethyl sulfone, citric acid, and at least one polysorbate; dietary supplement; stable dispersions in aqueous medium for oral administration |
| 06/11/2002 | US6403114 Having a reduced level of residual solvent(s); controlled-release microparticles having improved shelf-life |
| 06/11/2002 | US6403098 Buffer, sugar, phosphate, recombinant human serum albumin, polysorbate |
| 06/11/2002 | US6403090 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
| 06/11/2002 | US6403079 Using polypeptide |
| 06/11/2002 | US6403063 Applying polyurea; curing |
| 06/11/2002 | US6403057 Microcapsules, method of making and their use |
| 06/11/2002 | US6403056 Administering agent; applying ultrasonic frequency |
| 06/11/2002 | US6402997 Method for preparing microcapsule containing soluble iron using fatty acid ester |
| 06/11/2002 | US6402733 Intrapulmonary delivery of polypeptide growth factors and cytokines |
| 06/11/2002 | CA2327578A1 A method of introducing a central nervous system stimulent to aid in the human waking process |
| 06/11/2002 | CA2323849C Orally administrable solid ribavirin dosage forms and process for making them |
| 06/11/2002 | CA2159596C Method of producing liposomes |
| 06/11/2002 | CA2101760C Composition made of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids |
| 06/11/2002 | CA2074050C Diclofenac sodium plaster |
| 06/11/2002 | CA2048638C Fibroblast growth factor (fgf)-based stabilized compositions and the use thereof |
| 06/09/2002 | WO2002067993A1 Drug-releasing system of biodegradable polymer type |
| 06/06/2002 | WO2002044336A2 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
| 06/06/2002 | WO2002044232A2 Polyanhydrides |
| 06/06/2002 | WO2002044231A1 Surfactant-free cosmetic, dermatological and pharmaceutical agents |
| 06/06/2002 | WO2002044206A2 Membrane fusion proteins derived from reovirus |
| 06/06/2002 | WO2002044167A1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/06/2002 | WO2002043800A2 Devices and methods for controlled delivery from a drug delivery device |
| 06/06/2002 | WO2002043788A2 Method and apparatus for delivery of therapeutic from a delivery matrix |
| 06/06/2002 | WO2002043785A2 Intraocular implants for preventing transplant rejection in the eye |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043767A1 Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 06/06/2002 | WO2002043766A1 Medicinal compositions and process for producing the same |
| 06/06/2002 | WO2002043765A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 06/06/2002 | WO2002043756A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 06/06/2002 | WO2002043750A2 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| 06/06/2002 | WO2002043739A2 Dermatological formulations containing clindamycin and a zinc-salt |
| 06/06/2002 | WO2002043732A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | WO2002043729A1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid |
| 06/06/2002 | WO2002043723A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
| 06/06/2002 | WO2002043711A1 Adhesive preparation for external use |
| 06/06/2002 | WO2002043710A1 Pharmaceutical composition, the use thereof and method for producing said composition |
| 06/06/2002 | WO2002043709A1 Method for producing preparation containing bioactive substance |
| 06/06/2002 | WO2002043708A2 Magnetic particles for the targeted regional therapy |
| 06/06/2002 | WO2002043707A1 Pharmaceutical formulation |
| 06/06/2002 | WO2002043706A2 Prolamin-based sustained-release compositions and delayed-onset compositions |
| 06/06/2002 | WO2002043705A2 Aerodynamically light vaccine for active pulmonary immunization |
| 06/06/2002 | WO2002043704A1 Composition improved in solubility or oral absorbability |
| 06/06/2002 | WO2002043703A1 Powdery preparations and proecss for producing the same |
| 06/06/2002 | WO2002043702A2 Pharmaceutical compositions for inhalation |
| 06/06/2002 | WO2002043701A2 Method of making particles for use in a pharmaceutical composition |
| 06/06/2002 | WO2002043700A2 Particles for use in a pharmaceutical composition |
| 06/06/2002 | WO2002043699A2 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | WO2002043698A1 W/o/w composite emulsion |
| 06/06/2002 | WO2002043697A1 W/o/w composite emulsion |
| 06/06/2002 | WO2002043696A1 Solvent systems for pharmaceutical agents |
| 06/06/2002 | WO2002043695A2 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol |
| 06/06/2002 | WO2002043694A2 Edible pga(propylene glycol alginate) coating composition |
| 06/06/2002 | WO2002043693A2 Pharmaceutical compositions for inhalation |
| 06/06/2002 | WO2002043692A1 Method for making a cell activating implantable composition |
| 06/06/2002 | WO2002043691A1 Skin cream stimulating the surface bloodstream |
| 06/06/2002 | WO2002043686A2 Acid cosmetic, dermatological and pharmaceutical agents |
| 06/06/2002 | WO2002043685A2 Cosmetic and/or pharmaceutical emulsions |
| 06/06/2002 | WO2002043672A1 Fine-grained emulsions |
| 06/06/2002 | WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 06/06/2002 | WO2002043665A2 Ahf associated dispersion system and method for preparation |
| 06/06/2002 | WO2002043660A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | WO2002043659A2 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | WO2002043657A2 Improved pullulan free edible film compositions and methods of making the same |
| 06/06/2002 | WO2002043646A1 Methods and apparatus for making seamless capsules |
| 06/06/2002 | WO2002043611A1 Dispensing device |
| 06/06/2002 | WO2002043580A2 Production of microspheres |
| 06/06/2002 | WO2002043566A2 Devices and methods for treating low blood sugar levels |
| 06/06/2002 | WO2002043510A2 Methods of stabilizing fruit-concentrate powders |
| 06/06/2002 | WO2002028426A8 Split enveloped virus preparation |
| 06/06/2002 | WO2002028364A3 Stabilization of solid thyroid drug formulations |
| 06/06/2002 | WO2002026372A3 Instant water dissolvable encapsulate and process |
| 06/06/2002 | WO2002022172A3 Powdered/microfibrillated cellulose |
| 06/06/2002 | WO2002020555A3 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 06/06/2002 | WO2002015844A3 Antimicrobial composition and methods of use in the treatment of disease |
| 06/06/2002 | WO2002014448A3 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 06/06/2002 | WO2002007704A3 Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
| 06/06/2002 | WO2002007683B1 Antimicotic nail varnish composition |
| 06/06/2002 | WO2002003914A3 Improved thyroid hormone formulations |
| 06/06/2002 | WO2002000261A3 Surfactant-containing formulations for extended release of somatotropin |
| 06/06/2002 | WO2001093807A3 Transdermal delivery |
| 06/06/2002 | WO2001091696A3 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 06/06/2002 | WO2001080840A3 Cytotoxic agents comprising single-stranded and/or looped dna |
| 06/06/2002 | WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders |
| 06/06/2002 | WO2001054648A3 Treatment of disorders affecting vigilance related to myopathies |
| 06/06/2002 | WO2001049324A3 Novel colloid synthetic vectors for gene therapy |
| 06/06/2002 | WO2001042225A8 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/06/2002 | WO2001012232A8 Process to make a sustained release formulation |
| 06/06/2002 | WO2000075255A3 Pressure sensitive adhesive and biomedical electrodes using same |
| 06/06/2002 | US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc. |
| 06/06/2002 | US20020068720 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. |